or Try an Advanced Search...

    Technical Analysis for ELAB - ELEVAI Labs, Inc.

    Grade Last Price % Change Price Change
    F 0.03 -51.02% -0.03
    ELAB closed down 51.02 percent on Friday, November 1, 2024, on 5.82 times normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical ELAB trend table...
    Date Alert Name Type % Chg
    New 52 Week Closing Low Bearish 0.00%
    Volume Surge Other 0.00%
    Calm After Storm Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    New 52 Week Low Weakness 0.00%
    Wide Bands Range Expansion 0.00%
    Below Lower BB Weakness 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Gapped Down Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Older End-of-Day Signals for ELAB ...

       Recent Intraday Alerts

    Alert Time
    2x Volume Pace about 24 hours ago
    1.5x Volume Pace about 24 hours ago
    3x Volume Pace about 24 hours ago
    Down 5% about 24 hours ago
    Down 3% about 24 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    ELAB Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    ELEVAI Labs Inc. is a medical aesthetic company developing cutting-edge physician-dispensed skin care applications. The company solves unmet needs in the medical aesthetics space through a combination of cutting-edge science-driven and next-generation consumer applications. ELEVAI Labs develops topical aesthetic skin care cosmetic products for the physician-dispensed market, with a focus on leveraging a proprietary stem cell exosome technology.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Ointments Topical Medication

    Is ELAB a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 1 Why Charter Communications Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
    Oct 31 Why Carvana Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
    Oct 22 Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Engages Leading Contract Research Organization (CRO) to Support Regulatory Planning Efforts and Pre-IND Meeting with the Food and Drug Administration For EL-22 For The Treatment of Obesity
    Oct 21 Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Highlights Past Positive Preclinical Data Showing Potential of EL-32, A Dual Myostatin & Activin-A Blocker, For the Treatment of Obesity
    Oct 4 Elevai Labs Inc. Commences Offer to Exchange Up to 15,000,000 shares of Common Stock For Shares of Non Tradable. Locked Up Series B Preferred Stock
    Oct 3 Sector Update: Health Care Stocks Fall Late Afternoon
    Oct 3 REPEAT: Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Expands Patent Portfolio with Two New Filings for EL-22 in Muscle Loss Treatment for Obese Patients, Including GLP-1 Receptor Agonist Combinations
    Oct 3 Elevai Bioscience up on portfolio expansion with new filings for muscle loss treatment in obese patients
    Oct 3 Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Expands Patent Portfolio with Two New Filings for EL-22 in Muscle Loss Treatment for Obese Patients, Including GLP-1 Receptor Agonist Combinations
    Oct 2 Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Launch of Clinical Study Combining Its Flagship Topical Exosome Skincare Products with a Medical Aesthetic Energy Device
    See more ELAB news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 4.24
    52 Week Low 0.0283
    Average Volume 34,539,175
    200-Day Moving Average 0.51
    50-Day Moving Average 0.18
    20-Day Moving Average 0.09
    10-Day Moving Average 0.09
    Average True Range 0.03
    RSI (14) 23.66
    ADX 19.12
    +DI 33.66
    -DI 34.65
    Chandelier Exit (Long, 3 ATRs) 0.11
    Chandelier Exit (Short, 3 ATRs) 0.11
    Upper Bollinger Bands 0.13
    Lower Bollinger Band 0.06
    Percent B (%b) -0.4
    BandWidth 75.52
    MACD Line -0.03
    MACD Signal Line -0.03
    MACD Histogram 0.0015
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.05
    Resistance 3 (R3) 0.05 0.04 0.04
    Resistance 2 (R2) 0.04 0.04 0.04 0.04
    Resistance 1 (R1) 0.04 0.04 0.03 0.03 0.04
    Pivot Point 0.03 0.03 0.03 0.03 0.03
    Support 1 (S1) 0.02 0.03 0.02 0.02 0.02
    Support 2 (S2) 0.02 0.03 0.02 0.02
    Support 3 (S3) 0.01 0.02 0.01
    Support 4 (S4) 0.01